ERNA: Ernexa Therapeutics Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-10-30 | 13G amendment | Freebird Partners LP | 7.00% | SEC |
Institutional ownership (Q2 2026)
11 institutions reported holding $236K of Ernexa Therapeutics Inc. on Form 13F (0 the quarter before). 11 opened a new position and 0 sold out. Shares held by institutions: new.
| Largest holders | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 15,104 | $100K |
| VANGUARD FIDUCIARY TRUST CO | 8,336 | $55K |
| Dauntless Investment Group, LLC | 6,000 | $40K |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,684 | $38K |
| Tradewinds Capital Management, LLC | 361 | $2K |
| BlackRock, Inc. | 33 | $219 |
| ASSETMARK, INC | 5 | $33 |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $7 |
| SBI Securities Co., Ltd. | 1 | $7 |
| Steward Partners Investment Advisory, LLC | 0 | $1 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.